Andrews Patricia S
SEC Form 4 insider trading activity
Andrews Patricia S has filed 1 SEC Form 4 filing (1 transaction rows) across 1 company, with disclosures dating back to 2026. 1 of those filings fall inside the rolling window. Most recent filing: Feb 13, 2026.
On the most recent filing, Andrews Patricia S is listed as Director at ONCOLYTICS BIOTECH INC. Inside the rolling window, Andrews Patricia S reported 1 open-market purchase totaling $30K in ONCY and no open-market sales.
Companies traded
Other insiders at ONCY
Insider Buying
$30K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Andrews Patricia S made?
Andrews Patricia S has filed 1 SEC Form 4 filing (1 transaction rows) across 1 company since 2026.
Which companies does Andrews Patricia S trade?
Andrews Patricia S has filed SEC Form 4 disclosures for 1 company, including ONCY.
When was Andrews Patricia S's most recent SEC Form 4 filing?
Andrews Patricia S's most recent SEC Form 4 filing on Tracefour is dated Feb 13, 2026.
What is Andrews Patricia S's total buy and sell value in the current window?
Inside the rolling retention window, Andrews Patricia S bought $30K and sold $0 based on SEC Form 4 filings.
What was Andrews Patricia S's largest disclosed transaction?
The largest disclosed transaction in the current window is a purchase of 35,400 ONCY shares on 2026-02-12, worth $30K, per SEC Form 4 filings.